Myriad Genetics Inc (NASDAQ:MYGN)

27.33
BATS BZX Real-Time Price
As of 2:26pm ET
 -0.83 / -2.95%
Today’s Change
10.54
Today|||52-Week Range
33.97
+38.20%
Year-to-Date

Today’s Trading

Previous close28.16
Today’s open28.72
Day’s range27.26 - 28.72
Volume10,829
Average volume (3 months)829,604
Market cap$2.1B
Data as of 2:26pm ET, 04/12/2021

Growth & Valuation

Earnings growth (last year)-4,389.30%
Earnings growth (this year)--
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)-24.97%
P/E ratioNM
Price/Sales1.32
Price/Book2.29

Competitors

 Today’s
change
Today’s
% change
LNTHLantheus Holdings In...+0.09+0.43%
VIVOMeridian Bioscience ...-1.02-4.08%
TRILTrillium Therapeutic...-0.62-5.94%
CLDXCelldex Therapeutics...-0.12-0.58%
Data as of 2:25pm ET, 04/12/2021

Financials

Next reporting dateNovember 9, 2021
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$638.6M
Annual profit (last year)-$199.5M
Net profit margin-31.24%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Salt Lake City, Utah

Forecasts